Pathalys Pharma

At Pathalys #Pharma our mission is to improve the lives of #patients through enhanced #therapeutics that will advance the management of #chronic #kidneydisease.

[Pathalys Pharma @PathalysPharma]

Pathalys Pharma Secures $105 Million Series B Financing - https://t.co/pkXZtRlsOP #innovation

[Pathalys Pharma @PathalysPharma]

Pathalys enrolls first #patient in #phase3 program for upacicalcet ahead of schedule! #VentureCapital #innovation in #Kidney #disease https://t.co/4ad8dBR7mP

[Pathalys Pharma @PathalysPharma]

Pathalys has secured $150M in #equity and secured product #financing and also formed a strategic #collaboration with @LaunchTx to advance upacicalcet through #phase3 #clincialtrials.

For more information: https://t.co/1JhZVjOcVN

#venturecapital #renalcare #innovation

[BioWorld @BioWorld]

.@PathalysPharma launches with in-licensed CKD drug #upacicalcet ready for phase III
#startup #biotechstartup #kidneydisease #biotech #biopharma #biotechnology #BiotechNews #LifeSciencesNews
https://t.co/jLWaQLAPIR

[Pathalys Pharma @PathalysPharma]

When Pathalys #launched on March 1st, it launched with a novel #clinical stage asset, upacicalcet. Follow us here for updates on our two planned Ph3 #clinicaltrials and progess made with this new #venture. https://t.co/WDLPX5Z3pj #biopharma #kidney #innovation #VentureCapital

[Pathalys Pharma @PathalysPharma]

We are thrilled to announce that Neal Fowler, former CEO at @Liquidia_Corp, has been named #CEO at @PathalysPharma. Please join us in welcoming him aboard and click on the link to find out more about this exciting new #venture - https://t.co/SvVfxO0ydW.

[Pathalys Pharma @PathalysPharma]

Introducing Pathalys Pharma, Inc.! Today we announced our formation made possible through initial seed financing from DaVita Venture Group, part of @DaVita, and Catalys Pacific. Learn more about this exciting venture at https://t.co/WeYQAUo108. #biopharma #venturecapital #Kidney